EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

LVAD therapy as a catalyst to heart failure remission and myocardial recovery

Eman A Hamad, Mirnela Byku, Sharon B Larson, Filio Billia

Clinical Cardiology · 2023

DOI: 10.1002/clc.24094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Cardiology, 2023. Verfasst von Eman A Hamad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of chronic heart failure over the past decade has witnessed tremendous strides in medical optimization and device therapy including the use of left ventricular assist devices (LVAD). What we once thought of as irreversible damage to the myocardium is now demonstrating signs of reverse remodeling and recovery. Myocardial recovery on the structural, molecular, and hemodynamic level is necessary for sufficient recovery to withstand explant and achieve sustained recovery post‐LVAD. Guideline‐directed medical therapy and unloading have been shown to aid in recovery with the potential to successfully explant the LVAD. This review will summarize medical optimization, assessment for recovery, explant methodologies and outcomes post‐recovery with explant of durable LVAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart FailureHumansHeart VentriclesVentricular RemodelingMyocardium

Stichwörter der Autor:innen

GDMTLVADexplantrecovery

Autor:innen und Institutionen

  • Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
  • Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Baptist Heart Institute at Baptist Memorial Hospital, Memphis, Tennessee, USA.
  • Peter Munk Cardiac Center, University Health Network, Toronto, Ontario, Canada.

Zitieren

APA

Hamad, E. A., Byku, M., Larson, S. B., & Billia, F. (2023). LVAD therapy as a catalyst to heart failure remission and myocardial recovery. Clinical Cardiology. https://doi.org/10.1002/clc.24094

Vancouver

Hamad EA, Byku M, Larson SB, Billia F. LVAD therapy as a catalyst to heart failure remission and myocardial recovery. Clinical Cardiology. 2023. doi:10.1002/clc.24094

BibTeX
@article{Hamad2023,
  author = {Hamad, Eman A and Byku, Mirnela and Larson, Sharon B and Billia, Filio},
  title = {LVAD therapy as a catalyst to heart failure remission and myocardial recovery},
  journal = {Clinical Cardiology},
  year = {2023},
  doi = {10.1002/clc.24094}
}
Kostenlos starten →